178 related articles for article (PubMed ID: 7086685)
1. Cholestatic effect of harmol glucuronide in the rat. Prevention of harmol-induced cholestasis by increased formation of harmol sulfate.
Krijgsheld KR; Koster HJ; Scholtens E; Mulder GJ
J Pharmacol Exp Ther; 1982 Jun; 221(3):731-4. PubMed ID: 7086685
[TBL] [Abstract][Full Text] [Related]
2. Normal and retrograde perfusion to probe the zonal distribution of sulfation and glucuronidation activities of harmol in the perfused rat liver preparation.
Pang KS; Koster H; Halsema IC; Scholtens E; Mulder GJ; Stillwell RN
J Pharmacol Exp Ther; 1983 Mar; 224(3):647-53. PubMed ID: 6827487
[TBL] [Abstract][Full Text] [Related]
3. Metabolism of harmol and transport of harmol conjugates in isolated rat hepatocytes.
Sundheimer DW; Brendel K
Drug Metab Dispos; 1983; 11(5):433-40. PubMed ID: 6138228
[TBL] [Abstract][Full Text] [Related]
4. Alteration of transit time and direction of flow to probe the heterogeneous distribution of conjugating activities for harmol in the perfused rat liver preparation.
Dawson JR; Weitering JG; Mulder GJ; Stillwell RN; Pang KS
J Pharmacol Exp Ther; 1985 Sep; 234(3):691-7. PubMed ID: 4032287
[TBL] [Abstract][Full Text] [Related]
5. Biliary and urinary excretion of drug conjugates: effect of diuresis and choleresis on excretion of harmol sulphate and harmol glucuronide in the rat.
Jorritsma J; Meerman JH; Vonk RJ; Mulder GJ
Xenobiotica; 1979 Apr; 9(4):247-52. PubMed ID: 483860
[TBL] [Abstract][Full Text] [Related]
6. Kinetics of sulfation and glucuronidation of harmol in the perfused rat liver preparation. Disappearance of aberrances in glucuronidation kinetics by inhibition of sulfation.
Koster H; Halsema I; Scholtens E; Pang KS; Mulder GJ
Biochem Pharmacol; 1982 Oct; 31(19):3023-8. PubMed ID: 7150332
[TBL] [Abstract][Full Text] [Related]
7. Aberrant Pharmacokinetics of harmol in the perfused rat liver preparation: sulfate and glucuronide conjugations.
Pang KS; Koster H; Halsema IC; Scholtens E; Mulder GJ
J Pharmacol Exp Ther; 1981 Oct; 219(1):134-40. PubMed ID: 7288601
[No Abstract] [Full Text] [Related]
8. Sulphate and glucuronic acid conjugation of harmol in human fetal and adult liver tissue.
Steiner E; von Bahr C; Rane A
Dev Pharmacol Ther; 1982; 5(1-2):14-20. PubMed ID: 7151633
[TBL] [Abstract][Full Text] [Related]
9. Secretion of the organic anion harmol sulfate from liver into blood. Evidence for a carrier-mediated mechanism.
de Vries MH; Groothuis GM; Mulder GJ; Nguyen H; Meijer DK
Biochem Pharmacol; 1985 Jun; 34(12):2129-35. PubMed ID: 4004931
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of sulfation of phenols in vivo by 2,6-dichloro-4-nitrophenol: selectivity of its action in relation to other conjugations in the rat in vivo.
Koster H; Scholtens E; Mulder GJ
Med Biol; 1979 Oct; 57(5):340-4. PubMed ID: 522521
[TBL] [Abstract][Full Text] [Related]
11. Kinetics of sulfation in the rat in vivo and in the perfused rat liver.
Mulder GJ
Fed Proc; 1986 Jul; 45(8):2229-34. PubMed ID: 3087784
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial dysfunction and biotransformation of β-carboline alkaloids, harmine and harmaline, on isolated rat hepatocytes.
Nakagawa Y; Suzuki T; Ishii H; Ogata A; Nakae D
Chem Biol Interact; 2010 Dec; 188(3):393-403. PubMed ID: 20833158
[TBL] [Abstract][Full Text] [Related]
13. Extrahepatic sulfation and glucuronidation in the rat in vivo. Determination of the hepatic extraction ratio of harmol and the extrahepatic contribution to harmol conjugation.
Mulder GJ; Weitering JG; Scholtens E; Dawson JR; Pang KS
Biochem Pharmacol; 1984 Oct; 33(19):3081-7. PubMed ID: 6487358
[TBL] [Abstract][Full Text] [Related]
14. Characterization of cholestasis induced by estradiol-17 beta-D-glucuronide in the rat.
Meyers M; Slikker W; Pascoe G; Vore M
J Pharmacol Exp Ther; 1980 Jul; 214(1):87-93. PubMed ID: 7391975
[TBL] [Abstract][Full Text] [Related]
15. Factors influencing sulfation in isolated rat hepatocytes.
Sundheimer DW; Brendel K
Life Sci; 1984 Jan; 34(1):23-9. PubMed ID: 6694509
[TBL] [Abstract][Full Text] [Related]
16. D-cysteine as a selective precursor for inorganic sulfate in the rat in vivo. Effect of D-cysteine on the sulfation of harmol.
Glazenburg EJ; Jekel-Halsema IM; Baranczyk-Kuzma A; Krijgsheld KR; Mulder GJ
Biochem Pharmacol; 1984 Feb; 33(4):625-8. PubMed ID: 6704178
[TBL] [Abstract][Full Text] [Related]
17. Futile cycling between 4-methylumbelliferone and its conjugates in perfused rat liver.
Ratna S; Chiba M; Bandyopadhyay L; Pang KS
Hepatology; 1993 May; 17(5):838-53. PubMed ID: 8491453
[TBL] [Abstract][Full Text] [Related]
18. Taurocholate and steroid glucuronides: mutual protection against cholestasis in the isolated perfused rat liver.
Durham S; Vore M
J Pharmacol Exp Ther; 1986 May; 237(2):490-5. PubMed ID: 3701641
[TBL] [Abstract][Full Text] [Related]
19. Effect of glutathione depletion on sulfate activation and sulfate ester formation in rats.
Gregus Z; White C; Howell S; Klaassen CD
Biochem Pharmacol; 1988 Nov; 37(22):4307-12. PubMed ID: 3196355
[TBL] [Abstract][Full Text] [Related]
20. Synergistic effects of hypoxia and fasting on harmol elimination in the isolated perfused rat liver.
Angus PW; Mihaly GW; Morgan DJ; Smallwood RA
Biochem Pharmacol; 1988 Apr; 37(7):1207-12. PubMed ID: 3355595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
